Schistosomiasis artesunate, or mefloquine. A Cochrane review found tentative evidence that when used alone, metrifonate was as effective as praziquantel. Another agent, mefloquine, which has previously been used to treat and prevent malaria, was recognised in 2008–2009 to be effective against "Schistosoma". Historically, antimony potassium tartrate remained the treatment of choice for schistosomiasis until the development of praziquantel in the 1980s. The disease is found in tropical countries in Africa, the Caribbean, eastern South America, Southeast Asia, and the Middle East. "S. mansoni" is found in parts of South America and the Caribbean, Africa, and the Middle East; "S. haematobium" in
International Association for the Treatment of Sexual Offenders either individual, couple, family, or even group settings. The treatments offered are created and used to prevent any offending behavior and further victimization of others. The biomedical treatment is the use of pharmacological treatment. This type of therapy in the past has included the use of anti-androgens, antidepressants, and anti-anxiety, anti epileptic, antipsychotic, or other types of medicine. However, note that biomedical treatment is not limited to these medications. All medications have different turnouts for different individuals, so it is crucial to find the best fit and the most successful medication for that specific person to help treat them and